rVSV-ZEBOV

N/A

Report date: 2024/02/21 12:26:52

Base Information

Drug NamerVSV-ZEBOV
Drug Alias NameEbola vaccinePublic Health Agency of Canada's Ebola vaccinerVSV delta G ZEBOV GPEbola virus vaccineVSV delta G ZEBOV +[20] 
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsHemorrhagic Fever, Ebola
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2019/11/11
Country/TerritoryUnited StatesSierra LeoneGuinea +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPublic Health Agency Of Canada'S National Microbiology Laboratory
China Registration ClassN/A

Develop Information

Active CompaniesInstitut National De La Santé Et De La Recherche Médicale, France U979Merck Sharp & Dohme BvEmory University +[4] 
Inactive CompaniesInstitute Of Tropical Medicine, University Of TuebingenUniversity Of Sierra LeoneMerck Sharp & Dohme Corp +[7] 
Active IndicationsHemorrhagic Fever, Ebola
Inactive IndicationsN/A

Other Information

ATC CodeJ07BX
Related LinksWikipedia